🇺🇸 FDA
Patent

US 9962352

Creatine oral supplementation using creatine hydrochloride salt

granted A61KA61K31/185A61K31/195

Quick answer

US patent 9962352 (Creatine oral supplementation using creatine hydrochloride salt) held by BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA expires Mon May 03 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA
Grant date
Tue May 08 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 03 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/185, A61K31/195, A61K31/198, A61K31/661